Butalbital, Aspirin and Caffeine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceutical Corp. The primary component is Butalbital; Aspirin; Caffeine.
| Product ID | 0143-1785_576e3e85-d465-4c0f-9d8a-3a786e2becd2 |
| NDC | 0143-1785 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Butalbital, Aspirin and Caffeine |
| Generic Name | Butalbital, Aspirin And Caffeine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1979-06-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA086162 |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | BUTALBITAL; ASPIRIN; CAFFEINE |
| Active Ingredient Strength | 50 mg/1; mg/1; mg/1 |
| Pharm Classes | Barbiturates [CS],Barbiturate [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
| DEA Schedule | CIII |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1979-06-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Marketing Category | ANDA |
| Application Number | ANDA086162 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1979-06-05 |
| Marketing End Date | 2016-09-30 |
| Ingredient | Strength |
|---|---|
| BUTALBITAL | 50 mg/1 |
| SPL SET ID: | cae6b59d-13dc-49ea-ad4b-2f2bdae23840 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| UPC Code | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-1785 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
| 21695-354 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
| 42543-098 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
| 52959-370 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |
| 66336-619 | Butalbital, Aspirin and Caffeine | Butalbital, Aspirin and Caffeine |